{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:10:26Z","timestamp":1784545826328,"version":"3.55.0"},"reference-count":336,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020247","name":"University of Bisha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007470","name":"Shaqra University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.prp.2023.155023","type":"journal-article","created":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T02:37:25Z","timestamp":1702175845000},"page":"155023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"253","author":[{"given":"Osama A.","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Elballal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"El-Husseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad Gamil","family":"Khidr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar Mohammed","family":"El Tabaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Elazazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai A.","family":"Abd-Elmawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Elesawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henwa M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa A.","family":"El-Dakroury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Elrebehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousra","family":"Nomier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Ahmed","family":"Abdel-Reheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein M.","family":"El-Husseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla M.A.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.prp.2023.155023_bib1","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson's disease: a systematic review and meta\u2010analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"issue":"9996","key":"10.1016\/j.prp.2023.155023_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"9680","key":"10.1016\/j.prp.2023.155023_bib3","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2023.155023_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00702-004-0251-7","article-title":"Levodopa-induced dyskinesia in Parkinson\u2019s disease","volume":"112","author":"Brotchie","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.prp.2023.155023_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated \u03b1-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/cells9040841","article-title":"The promise and challenges of developing miRNA-based therapeutics for Parkinson\u2019s disease","volume":"9","author":"Titze-de-Almeida","year":"2020","journal-title":"Cells"},{"issue":"S6","key":"10.1016\/j.prp.2023.155023_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.10557","article-title":"Neuropathological spectrum of synucleinopathies","volume":"18","author":"Jellinger","year":"2003","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"issue":"6","key":"10.1016\/j.prp.2023.155023_bib9","article-title":"From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models","volume":"1878","author":"Abdelmaksoud","year":"2023","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prp.2023.155023_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson\u2019s disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol. brain"},{"issue":"5","key":"10.1016\/j.prp.2023.155023_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/jnc.12949","article-title":"LRRK2 pathobiology in Parkinson's disease","volume":"131","author":"Martin","year":"2014","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.prp.2023.155023_bib12","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009365","article-title":"Programmed cell death in Parkinson's disease","volume":"2","author":"Venderova","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.prp.2023.155023_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/WCO.0000000000000215","article-title":"\u03b1-Synuclein and Lewy pathology in Parkinson's disease","volume":"28","author":"Kalia","year":"2015","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.prp.2023.155023_bib15","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.prp.2023.155023_bib16","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s12035-016-9879-1","article-title":"Brain iron metabolism dysfunction in Parkinson\u2019s disease","volume":"54","author":"Jiang","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.prp.2023.155023_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/1570159X13666151030102847","article-title":"LRRK2 kinase inhibition as a therapeutic strategy for Parkinson\u2019s disease, where do we stand?","volume":"14","author":"Taymans","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib18","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1111\/ejn.14689","article-title":"The contribution of Parkin, PINK1 and DJ\u20101 genes to selective neuronal degeneration in Parkinson's disease","volume":"52","author":"van der Vlag","year":"2020","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mds.27583","article-title":"Glucocerebrosidase mutations and synucleinopathies: toward a model of precision medicine","volume":"34","author":"Blandini","year":"2019","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2011.12.046","article-title":"MicroRNAs in Parkinson's disease","volume":"46","author":"Mouradian","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.prp.2023.155023_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154510","article-title":"The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance \u2013 A focus on signaling pathways interplay","volume":"246","author":"Hegazy","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154316","article-title":"miRNAs role in bladder cancer pathogenesis and targeted therapy","author":"El-Mahdy","year":"2023","journal-title":"Signal. Pathw. Inter. -A Rev., Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib23","article-title":"miRNAs role in cervical cancer pathogenesis and targeted therapy: signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154371","article-title":"Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib25","article-title":"miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance\u2013an emphasis on the interaction of signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154411","article-title":"The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154424","article-title":"miRNAs as potential game-changers in melanoma: a comprehensive review","author":"Abd-Allah","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154437","article-title":"The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy","author":"Zaki","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121667","article-title":"An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer","author":"Fathi","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.155023_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154438","article-title":"Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance-A review","author":"Al-Noshokaty","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib31","article-title":"A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154439","article-title":"miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses","volume":"245","author":"Elballal","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154457","article-title":"miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses","author":"El-Mahdy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121697","article-title":"Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats","volume":"323","author":"Allam","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.155023_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105195","article-title":"Impact of the mother's gut microbiota on infant microbiome and brain development","author":"Mady","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.prp.2023.155023_bib36","article-title":"The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154511","article-title":"miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay","author":"Elshaer","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154557","article-title":"miR-509-5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11","author":"Elrebehy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib39","article-title":"miRNAs as potential game-changers in retinoblastoma: future clinical and medicinal uses","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154584","article-title":"The potential role of miRNAs in the pathogenesis of salivary gland cancer \u2013 a Focus on signaling pathways interplay","volume":"247","author":"Abulsoud","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154590","article-title":"miRNAs orchestration of salivary gland cancer- particular emphasis on diagnosis, progression, and drug resistance","author":"El-Husseiny","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib42","article-title":"The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - a Focus on signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154612","article-title":"miRNAs orchestration of testicular germ cell tumors - particular emphasis on diagnosis, progression and drug resistance","author":"Elesawy","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154665","article-title":"miRNAs orchestration of adrenocortical carcinoma - particular emphasis on diagnosis, progression and drug resistance","author":"El-Dakroury","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib45","article-title":"The potential role of miRNAs in the pathogenesis of gallbladder cancer - a focus on signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154684","article-title":"miRNAs orchestration of gallbladder cancer - Particular emphasis on diagnosis, progression and drug resistance","author":"Shahin","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154690","article-title":"The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma \u2013 a focus on signaling pathways interplay","volume":"248","author":"Midan","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154763","article-title":"miRNAs driving diagnosis, prognosis and progression in Merkel cell carcinoma","volume":"249","author":"Al-Noshokaty","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154771","article-title":"The emerging role of miRNAs in Merkel cell carcinoma pathogenesis: signaling pathway crosstalk","author":"Rizk","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154817","article-title":"Melodic maestros: unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma","volume":"250","author":"Abd-Elmawla","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154856","article-title":"Possible role of miRNAs in pheochromocytoma pathology - signaling pathways interaction","author":"Elkhawaga","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154857","article-title":"From strings to signals: Unraveling the impact of miRNAs on diagnosis, and progression of colorectal cancer","author":"Mohammed","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154855","article-title":"Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer","author":"Abulsoud","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib54","article-title":"From diagnosis to resistance: a symphony of miRNAs in pheochromocytoma progression and treatment response","author":"Elsakka","year":"2023","journal-title":"Naunyn-Schmiede 'S. Arch. Pharmacol."},{"key":"10.1016\/j.prp.2023.155023_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154947","article-title":"Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma","author":"Salman","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154375","article-title":"The role of miRNAs in liver diseases: Potential therapeutic and clinical applications","volume":"243","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib57","article-title":"miRNAs as potential game-changers in bone diseases: Future medicinal and clinical Uses","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154704","article-title":"miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma","volume":"248","author":"Elkady","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154715","article-title":"Decoding the role of miRNAs in multiple myeloma pathogenesis: a focus on signaling pathways","author":"Yehia","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154880","article-title":"The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistance","volume":"251","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154613","article-title":"miRNAs orchestration of cardiovascular diseases \u2013 particular emphasis on diagnosis, and progression","volume":"248","author":"Elsakka","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154624","article-title":"The potential role of miRNAs in the pathogenesis of cardiovascular diseases \u2013 a focus on signaling pathways interplay","volume":"248","author":"Khidr","year":"2023","journal-title":"Pathol. - Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib63","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.sjbs.2021.02.001","article-title":"MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8","volume":"28","author":"Elkady","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.prp.2023.155023_bib64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/DMSO.S187422","article-title":"Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients","author":"Bakr Zaki","year":"2019","journal-title":"Diabetes, Metab. Syndr. Obes.: Targets Ther."},{"issue":"7","key":"10.1016\/j.prp.2023.155023_bib65","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcjd.2020.12.005","article-title":"Circulating miR-148a-5p and miR-21-5p as novel diagnostic biomarkers in adult Egyptian male patients with metabolic syndrome","volume":"45","author":"Doghish","year":"2021","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.prp.2023.155023_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154790","article-title":"The interplay between toxoplasmosis and host miRNAs: Mechanisms and consequences","volume":"250","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121321","article-title":"miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers","volume":"314","author":"Doghish","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.155023_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154512","article-title":"Long non-coding RNAs and rheumatoid arthritis: Pathogenesis and clinical implications","author":"Elazazy","year":"2023","journal-title":"Pathol. - Res. Pract."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.106978","article-title":"miRNAs as cornerstones in diabetic microvascular complications","volume":"138","author":"Ismail","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.prp.2023.155023_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123189","article-title":"The role of miRNAs in insulin resistance and diabetic macrovascular complications \u2013 a review","volume":"230","author":"Abdel Mageed","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.155023_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121382","article-title":"miRNAs as cornerstones in adipogenesis and obesity","volume":"315","author":"Elkhawaga","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib72","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.dsx.2018.11.058","article-title":"Plasma endoglin in Type2 diabetic patients with nephropathy","volume":"13","author":"Doghish","year":"2019","journal-title":"Diabetes Metab. Syndr.: Clin. Res. Rev."},{"issue":"10","key":"10.1016\/j.prp.2023.155023_bib73","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/cbin.11653","article-title":"miRNAs; a novel strategy for the treatment of COVID\u201019","volume":"45","author":"Ying","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.prp.2023.155023_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113977","article-title":"Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions","volume":"157","author":"Abulsoud","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.prp.2023.155023_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271271","article-title":"Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt","volume":"17","author":"Ismail","year":"2022","journal-title":"Plos One"},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249346","article-title":"Clinical characteristics of Egyptian male patients with COVID\u201019 acute respiratory distress syndrome","volume":"16","author":"Doghish","year":"2021","journal-title":"Plos One"},{"key":"10.1016\/j.prp.2023.155023_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112681","article-title":"MicroRNAs in Alzheimer's disease: potential diagnostic markers and therapeutic targets","volume":"148","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.155023_bib78","unstructured":"K.I. Eissa, M.M. Kamel, L.W. Mohamed, A.S. Doghish, R. Alnajjar, A.A. Al\u2010Karmalawy, A.E. Kassab, Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease, Drug Dev. Res."},{"issue":"8","key":"10.1016\/j.prp.2023.155023_bib79","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/ph16081123","article-title":"Alvespimycin exhibits potential anti-TGF-\u03b2 signaling in the setting of a proteasome activator in rats with bleomycin-induced pulmonary fibrosis: a promising novel approach","volume":"16","author":"Mohammed","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib80","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/2229-3485.179431","article-title":"MicroRNA therapeutics: discovering novel targets and developing specific therapy","volume":"7","author":"Christopher","year":"2016","journal-title":"Perspect. Clin. Res."},{"issue":"12","key":"10.1016\/j.prp.2023.155023_bib81","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4103\/1673-5374.221147","article-title":"MicroRNAs in Parkinson's disease and emerging therapeutic targets","volume":"12","author":"Martinez","year":"2017","journal-title":"Neural Regen. Res."},{"issue":"8","key":"10.1016\/j.prp.2023.155023_bib82","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009258","article-title":"Parkinson\u2019s disease and parkinsonism: neuropathology","volume":"2","author":"Dickson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"10","key":"10.1016\/j.prp.2023.155023_bib83","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/ph15101262","article-title":"Identification of novel cyanopyridones and pyrido [2, 3-D] pyrimidines as anticancer agents with dual VEGFR-2\/HER-2 inhibitory action: synthesis, biological evaluation and molecular docking studies","volume":"15","author":"Al-Warhi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2023.155023_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154211","article-title":"Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase","volume":"240","author":"Ismail","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108656","article-title":"Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase","volume":"160","author":"Ismail","year":"2020","journal-title":"Steroids"},{"key":"10.1016\/j.prp.2023.155023_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136336","article-title":"New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story","volume":"1294","author":"Eissa","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.prp.2023.155023_bib87","unstructured":"S.A. El-Metwally, H. Elkady, M. Hagras, E.B. Elkaeed, B.A. Alsfouk, A.S. Doghish, I.M. Ibrahim, M.S. Taghour, D.Z. Husein, A.M. Metwaly, I.H. Eissa, Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-d]pyrimidine, Future Medicinal Chemistry 0(0) null. DOI 10.4155\/fmc-2023\u20130130."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib88","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/14756366.2021.1901089","article-title":"Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"36","author":"Kassab","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.prp.2023.155023_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106729","article-title":"Development of pyrolo[2,3-c]pyrazole, pyrolo[2,3-d]pyrimidine and their bioisosteres as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological evaluation and molecular dynamics investigations","author":"Azmy","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"15","key":"10.1016\/j.prp.2023.155023_bib90","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.3390\/molecules28155812","article-title":"Antimicrobial, antibiofilm, and anticancer activities of syzygium aromaticum essential oil nanoemulsion","volume":"28","author":"Shehabeldine","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2023.155023_bib91","article-title":"The journey of boswellic acids from synthesis to pharmacological activities","author":"Ragab","year":"2023","journal-title":"Naunyn-Schmiede 'S. Arch. Pharmacol."},{"issue":"19","key":"10.1016\/j.prp.2023.155023_bib92","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.3390\/molecules28196910","article-title":"Thymus vulgaris oil nanoemulsion: synthesis, characterization, antimicrobial and anticancer activities","volume":"28","author":"Doghish","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2023.155023_bib93","article-title":"Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: synthesis, characterization, antimicrobial, and anticancer activities","volume":"77","author":"Doghish","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"46","key":"10.1016\/j.prp.2023.155023_bib94","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1039\/D1RA04345E","article-title":"Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer","volume":"11","author":"Doghish","year":"2021","journal-title":"RSC Adv."},{"issue":"16","key":"10.1016\/j.prp.2023.155023_bib95","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/polym14163352","article-title":"Synthesis of silver nanocomposite based on carboxymethyl cellulose: Antibacterial, antifungal and anticancer activities","volume":"14","author":"Salem","year":"2022","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib96","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2021.2015343","article-title":"New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies","volume":"37","author":"Elkady","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.prp.2023.155023_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154807","article-title":"Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression","volume":"250","author":"Ghanem","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib98","doi-asserted-by":"crossref","unstructured":"R. Abdelhady, S. Saber, M.A. Abdel-Reheim, M.M.S. Alamri, J. Alfaifi, M.I. Adam, L.A. Saleh, A.I. Farag, E.A. Elmorsy, H.S. El-wakeel, Unveiling the therapeutic potential of exogenous \u03b2-hydroxybutyrate for chronic colitis in rats: Novel insights on autophagy, apoptosis, and pyroptosis, Frontiers in Pharmacology 14 1239025.","DOI":"10.3389\/fphar.2023.1239025"},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib99","article-title":"Protein binding partners of dysregulated miRNAs in parkinson's disease serum","volume":"10","author":"Ruf","year":"2021"},{"issue":"5","key":"10.1016\/j.prp.2023.155023_bib100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000525639","article-title":"Descriptive epidemiology of neurodegenerative diseases: what are the critical questions?","volume":"56","author":"Logroscino","year":"2022","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib101","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The role of oxidative stress in neurodegenerative diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Neurobiol."},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib102","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/jbcpp-2019-0270","article-title":"6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson disease suppressed by pretreatment with hesperidin through activating L-type calcium channels","volume":"32","author":"Elyasi","year":"2020","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.prp.2023.155023_bib103","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bcp.2017.12.001","article-title":"Dopamine promotes cellular iron accumulation and oxidative stress responses in macrophages","volume":"148","author":"Dichtl","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib104","doi-asserted-by":"crossref","first-page":"269","DOI":"10.55782\/ane-2011-1847","article-title":"Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine)-induced mouse model of Parkinson\u2019s disease","volume":"71","author":"Yokoyama","year":"2011","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.prp.2023.155023_bib105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"9","key":"10.1016\/j.prp.2023.155023_bib106","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.freeradbiomed.2012.08.569","article-title":"Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease\u2014resemblance to the effect of amphetamine drugs of abuse","volume":"53","author":"Perfeito","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"S136","key":"10.1016\/j.prp.2023.155023_bib107","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0404.1991.tb05013.x","article-title":"Oxidative stress as a cause of Parkinson's disease","volume":"84","author":"Jenner","year":"1991","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib108","first-page":"1","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.prp.2023.155023_bib109","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.genrep.2016.09.001","article-title":"Matrix metalloproteinase (MMP)-2\u20131306\u2009C> T gene polymorphism affects circulating levels of MMP-2 in Egyptian asthmatic patients","volume":"5","author":"Elkady","year":"2016","journal-title":"Gene Rep."},{"issue":"8","key":"10.1016\/j.prp.2023.155023_bib110","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/mds.28064","article-title":"Mitochondrial complex 1, sigma 1, and synaptic vesicle 2A in early drug\u2010naive Parkinson's disease","volume":"35","author":"Wilson","year":"2020","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.prp.2023.155023_bib111","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u03b1-Synuclein misfolding and aggregation: Implications in Parkinson\u2019s disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Proteins Proteom."},{"key":"10.1016\/j.prp.2023.155023_bib112","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.prp.2023.155023_bib113","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jnc.14810","article-title":"The physiological role of \u03b1\u2010synuclein and its relationship to Parkinson\u2019s Disease","volume":"150","author":"Sulzer","year":"2019","journal-title":"J. Neurochem."},{"issue":"5999","key":"10.1016\/j.prp.2023.155023_bib114","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"issue":"S2","key":"10.1016\/j.prp.2023.155023_bib115","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.21573","article-title":"What causes cell death in Parkinson's disease?","volume":"64","author":"Gupta","year":"2008","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"issue":"3","key":"10.1016\/j.prp.2023.155023_bib116","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng.300","article-title":"\u03b1-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity","volume":"41","author":"Gitler","year":"2009","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.prp.2023.155023_bib117","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbadis.2008.10.005","article-title":"Genetic models of Parkinson disease","volume":"1792","author":"Lim","year":"2009","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib118","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.prp.2023.155023_bib119","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4784268","article-title":"Linking neuroinflammation and neurodegeneration in Parkinson\u2019s disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.prp.2023.155023_bib120","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/401264","article-title":"Oxidative stress and microglial cells in Parkinson's disease","volume":"2012","author":"Peterson","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.prp.2023.155023_bib121","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3389\/fimmu.2017.01905","article-title":"Neuroinflammation: microglia and T cells get ready to tango","volume":"8","author":"Schetters","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2023.155023_bib122","doi-asserted-by":"crossref","DOI":"10.1172\/JCI36470","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","author":"Brochard","year":"2008","journal-title":"J. Clin. Investig. 119(1"},{"key":"10.1016\/j.prp.2023.155023_bib123","unstructured":"A. Condo, S. Baharlou, Abdominal Pain: Obstruction Relieved but Problem Unresolved, JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, WILEY 111 RIVER ST, HOBOKEN 07030\u20135774, NJ USA, 2020, pp. S189-S190."},{"key":"10.1016\/j.prp.2023.155023_bib124","unstructured":"Y.D. Edwards, Identifying poorly met demand: the impact of product beliefs on attribute importance, The Ohio State University2002."},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib125","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ana.25557","article-title":"Increased immune activation by pathologic \u03b1\u2010synuclein in parkinson's disease","volume":"86","author":"Grozdanov","year":"2019","journal-title":"Ann. Neurol."},{"issue":"18","key":"10.1016\/j.prp.2023.155023_bib126","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2174\/138161207780858429","article-title":"Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications","volume":"13","author":"Wilms","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.prp.2023.155023_bib127","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s12035-018-1274-7","article-title":"Copper increases brain oxidative stress and enhances the ability of 6-hydroxydopamine to cause dopaminergic degeneration in a rat model of Parkinson\u2019s disease","volume":"56","author":"Cruces-Sande","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2023.155023_bib128","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10534-016-9942-4","article-title":"The neurotoxicity of iron, copper and cobalt in Parkinson\u2019s disease through ROS-mediated mechanisms","volume":"29","author":"Lan","year":"2016","journal-title":"Biometals"},{"issue":"19","key":"10.1016\/j.prp.2023.155023_bib129","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.3390\/ijerph16193546","article-title":"New insights on the role of manganese in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"16","author":"Martins","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuro.2012.01.010","article-title":"Industrial toxicants and Parkinson's disease","volume":"33","author":"Caudle","year":"2012","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib131","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/toxsci\/kfz069","article-title":"Developmental dieldrin exposure alters DNA methylation at genes related to dopaminergic neuron development and Parkinson\u2019s disease in mouse midbrain","volume":"169","author":"Kochmanski","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib132","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5114\/fn.2019.89857","article-title":"Rotenone: From modelling to implication in Parkinson\u2019s disease","volume":"57","author":"Radad","year":"2019","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.prp.2023.155023_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00218","article-title":"Parkinson's disease and the environment","author":"Ball","year":"2019","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib134","article-title":"DJ-1 deficiency impairs glutamate uptake into astrocytes via the regulation of flotillin-1 and caveolin-1 expression","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.prp.2023.155023_bib135","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/glia.23482","article-title":"Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammation","volume":"66","author":"Singh","year":"2018","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib136","first-page":"1","article-title":"PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes","volume":"9","author":"Choi","year":"2016","journal-title":"Mol. brain"},{"key":"10.1016\/j.prp.2023.155023_bib137","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12035-020-02114-x","article-title":"Overexpression of \u03b1-synuclein reorganises growth factor profile of human astrocytes","volume":"58","author":"\u015eeng\u00fcl","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.prp.2023.155023_bib138","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/mds.27994","article-title":"Lysosome and inflammatory defects in GBA1\u2013mutant astrocytes are normalized by LRRK2 inhibition","volume":"35","author":"Sanyal","year":"2020","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.prp.2023.155023_bib139","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1101\/gr.209643.116","article-title":"Multiparameter functional diversity of human C2H2 zinc finger proteins","volume":"26","author":"Schmitges","year":"2016","journal-title":"Genome Res."},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","article-title":"Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson's disease","volume":"12","author":"di Domenico","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.prp.2023.155023_bib141","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nbd.2019.05.006","article-title":"RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes","volume":"129","author":"Booth","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.prp.2023.155023_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104647","article-title":"A characterization of Gaucher iPS-derived astrocytes: potential implications for Parkinson's disease","volume":"134","author":"Aflaki","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.prp.2023.155023_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.prp.2023.155023_bib144","article-title":"Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association","volume":"240","author":"El-Sheikh","year":"2022","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2023.155023_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2022.09.209","article-title":"Interactome battling of lncRNA CCDC144NL-AS1: Its role in the emergence and ferocity of cancer and beyond","author":"Abd El Fattah","year":"2022","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.155023_bib146","article-title":"Defining disease-related modules based on weighted miRNA synergistic network","volume":"152","author":"Li","year":"2022","journal-title":"Comput. Biol. Med"},{"issue":"3","key":"10.1016\/j.prp.2023.155023_bib147","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ncrna.2023.03.004","article-title":"Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of \u03b2-catenin protein level","volume":"8","author":"Bakr","year":"2023","journal-title":"Non-coding RNA Res."},{"issue":"7014","key":"10.1016\/j.prp.2023.155023_bib148","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.prp.2023.155023_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2022.08.002","article-title":"Mitochondrial miRNAs (MitomiRs): their potential roles in breast and other cancers","author":"Erturk","year":"2022","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.prp.2023.155023_bib150","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41477-021-01000-1","article-title":"Structural basis of microRNA processing by Dicer-like 1","volume":"7","author":"Wei","year":"2021","journal-title":"Nat. Plants"},{"issue":"11","key":"10.1016\/j.prp.2023.155023_bib151","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.1919710","article-title":"Emerging paradigms of regulated microRNA processing","volume":"24","author":"Newman","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2023.155023_bib152","doi-asserted-by":"crossref","unstructured":"K. Ergin, R. \u00c7etinkaya, Regulation of microRNAs, miRNomics, Springer2022, pp. 1\u201332.","DOI":"10.1007\/978-1-0716-1170-8_1"},{"issue":"7149","key":"10.1016\/j.prp.2023.155023_bib153","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.prp.2023.155023_bib154","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1101\/gad.1705308","article-title":"Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs","volume":"22","author":"Babiarz","year":"2008","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.prp.2023.155023_bib155","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr. Biol.: CB"},{"issue":"3","key":"10.1016\/j.prp.2023.155023_bib156","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201744853","article-title":"The dynamic recruitment of TRBP to neuronal membranes mediates dendritogenesis during development","volume":"19","author":"Antoniou","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.prp.2023.155023_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154567","article-title":"The long non-coding RNA ZFAS1 promotes colorectal cancer progression via miR200b\/ZEB1 axis","volume":"247","author":"Salman","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154570","article-title":"LncRNA NNT-AS1\/hsa-miR-485\u20135p\/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: a step toward ncRNA Precision","volume":"247","author":"El-Sheikh","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126739","article-title":"CCDC144NL-AS1\/hsa-miR-143-3p\/HMGA2 interaction: In-silico and clinically implicated in CRC progression, correlated to tumor stage and size in case-controlled study; step toward ncRNA precision","volume":"253","author":"Abd El Fattah","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.155023_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154509","article-title":"Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: A review","volume":"246","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib161","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mgene.2018.11.006","article-title":"Diagnostic Significance of miR-639 and miR-10b in \u0392reast Cancer Patients","volume":"19","author":"Ismail","year":"2019","journal-title":"Meta Gene"},{"issue":"23","key":"10.1016\/j.prp.2023.155023_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236055","article-title":"Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases","volume":"20","author":"Konovalova","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.155023_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00455","article-title":"microRNAs sculpt neuronal communication in a tight balance that is lost in neurological disease","volume":"11","author":"Thomas","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.prp.2023.155023_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120675","article-title":"Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-\u03baB pathways and LncRNA-AF085935\/GPC3 axis","author":"Al-Noshokaty","year":"2022","journal-title":"J. Life Sci."},{"key":"10.1016\/j.prp.2023.155023_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120325","article-title":"Exosomal-long non-coding RNAs journey in colorectal cancer: Evil and goodness faces of key players","volume":"292","author":"Rizk","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.155023_bib166","article-title":"A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson\u2019s Disease","volume":"2023","author":"Szel\u0105gowski","year":"2023"},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib167","first-page":"120","article-title":"diseases, Impact of gene mutation in the development of Parkinson\u2019s disease","volume":"6","author":"Selvaraj","year":"2019"},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib168","first-page":"a008888","article-title":"Genetics of Parkinson\u2019s disease","volume":"2","author":"Klein","year":"2012"},{"key":"10.1016\/j.prp.2023.155023_bib169","article-title":"The lncRNAs UCA1 and CRNDE target miR-145\/TLR4\/NF-\u049bB\/TNF-\u03b1 axis in acetic acid-induced ulcerative colitis model: The beneficial role of 3","volume":"121","author":"El-Boghdady","year":"2023","journal-title":"3-Diindolylmethane"},{"key":"10.1016\/j.prp.2023.155023_bib170","doi-asserted-by":"crossref","unstructured":"M.A. Kortam, N. Elfar, O.G. Shaker, N.A. El-Boghdady, M.A. Abd-Elmawla, MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN\/AKT\/IRF-3\/IFN-\u03b2 Axis, New Clinical Insights 14 (6) (2023) 1107\u20131118.","DOI":"10.1021\/acschemneuro.2c00653"},{"key":"10.1016\/j.prp.2023.155023_bib171","doi-asserted-by":"crossref","unstructured":"M.A. Abd-Elmawla, R.M. Essam, K.A. Ahmed, M. Abdelmonem, Implication of Wnt\/GSK-3\u03b2\/\u03b2-Catenin Signaling in the Pathogenesis of Mood Disturbances Associated with Hyperthyroidism in Rats: Potential Therapeutic Effect of Naringin, (2023).","DOI":"10.1021\/acschemneuro.3c00013"},{"key":"10.1016\/j.prp.2023.155023_bib172","doi-asserted-by":"crossref","unstructured":"M.A. Abd-Elmawla, E. Abdelalim, K.A. Ahmed, S.M. Rizk, The neuroprotective effect of pterostilbene on oxaliplatin-induced peripheral neuropathy via its anti-inflammatory, anti-oxidative and anti-apoptotic effects, Comparative study with celecoxib 315 (2023) 121364.","DOI":"10.1016\/j.lfs.2022.121364"},{"key":"10.1016\/j.prp.2023.155023_bib173","doi-asserted-by":"crossref","unstructured":"M. Rango, G. Dossi, L. Squarcina, C. Bonifati, Brain Mitochondrial Impairment in Early\u2010Onset Parkinson\u2019s Disease With or Without PINK1, Mutation 35 (3) (2020) 504\u2013507.","DOI":"10.1002\/mds.27946"},{"key":"10.1016\/j.prp.2023.155023_bib174","doi-asserted-by":"crossref","unstructured":"S. Larsen, Z. Hanss, R. Kr\u00fcger, The genetic architecture of mitochondrial dysfunction in Parkinson\u2019s disease 373 (2018) 21\u201337.","DOI":"10.1007\/s00441-017-2768-8"},{"key":"10.1016\/j.prp.2023.155023_bib175","doi-asserted-by":"crossref","unstructured":"F. Qiu, Y. Wu, G. Xie, H. Cao, M. Du, H. Jiang, MiRNA-1976 regulates the apoptosis of dopaminergic neurons by targeting the PINK1, gene 22 (2) (2023) 45.","DOI":"10.31083\/j.jin2202045"},{"key":"10.1016\/j.prp.2023.155023_bib176","doi-asserted-by":"crossref","unstructured":"J. Kim, F.C. Fiesel, K.C. Belmonte, R. Hudec, W.-X. Wang, C. Kim, P.T. Nelson, W. Springer, J. Kim, miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1), 11(1) (2016) 1\u201316.","DOI":"10.1186\/s13024-016-0121-4"},{"key":"10.1016\/j.prp.2023.155023_bib177","doi-asserted-by":"crossref","unstructured":"S. Chandrasekaran, D. Bonchev, A network view on Parkinson\u2019s disease 7 (8) (2013) e201304004.","DOI":"10.5936\/csbj.201304004"},{"issue":"19","key":"10.1016\/j.prp.2023.155023_bib178","first-page":"13434","article-title":"MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant","volume":"289","author":"Shi","year":"2014"},{"key":"10.1016\/j.prp.2023.155023_bib179","doi-asserted-by":"crossref","unstructured":"Y. Yao, Y. Xue, J. Ma, C. Shang, P. Wang, L. Liu, W. Liu, Z. Li, S. Qu, Z. Li, MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K\/AKT signaling, pathways 9 (4) (2014) e95060.","DOI":"10.1371\/journal.pone.0095060"},{"key":"10.1016\/j.prp.2023.155023_bib180","doi-asserted-by":"crossref","unstructured":"K.-H. Ling, P.J. Brautigan, C.N. Hahn, T. Daish, J.R. Rayner, P.-S. Cheah, J.M. Raison, S. Piltz, J.R. Mann, D.M. Mattiske, Deep sequencing analysis of the developing mouse brain reveals a novel, microRNA 12 (2011) 1\u201315.","DOI":"10.1186\/1471-2164-12-176"},{"key":"10.1016\/j.prp.2023.155023_bib181","doi-asserted-by":"crossref","unstructured":"I. Choi, J.H. Woo, I. Jou, E.-h Joe, PINK1 deficiency decreases expression levels of mir-326, mir-330, and mir-3099 during brain development and neural stem cell differentiation 25 (1) (2016) 14.","DOI":"10.5607\/en.2016.25.1.14"},{"key":"10.1016\/j.prp.2023.155023_bib182","doi-asserted-by":"crossref","unstructured":"M. Seirafi, G. Kozlov, K. Gehring, Parkin structure and function 282 (11) (2015) 2076\u20132088.","DOI":"10.1111\/febs.13249"},{"key":"10.1016\/j.prp.2023.155023_bib183","doi-asserted-by":"crossref","unstructured":"D. Narendra, A. Tanaka, D.-F. Suen, R. Youle, Parkin is recruited selectively to impaired mitochondria and promotes their, autophagy 183 (5) (2008) 795\u2013803.","DOI":"10.1083\/jcb.200809125"},{"key":"10.1016\/j.prp.2023.155023_bib184","doi-asserted-by":"crossref","unstructured":"F. Koyano, K. Okatsu, H. Kosako, Y. Tamura, E. Go, M. Kimura, Y. Kimura, H. Tsuchiya, H. Yoshihara, T. Hirokawa, Ubiquitin is phosphorylated by PINK1 to activate parkin, 510(7503) (2014) 162\u2013166.","DOI":"10.1038\/nature13392"},{"key":"10.1016\/j.prp.2023.155023_bib185","doi-asserted-by":"crossref","unstructured":"J. Zhou, Y. Zhao, Z. Li, M. Zhu, Z. Wang, Y. Li, T. Xu, D. Feng, S. Zhang, F. Tang, miR-103a-3p regulates mitophagy in Parkinson\u2019s disease through Parkin\/Ambra1 signaling, 160 (2020) 105197.","DOI":"10.1016\/j.phrs.2020.105197"},{"key":"10.1016\/j.prp.2023.155023_bib186","doi-asserted-by":"crossref","unstructured":"A. Di Rita, F. Strappazzon, AMBRA1, a Novel BH3-Like Protein: New Insights Into the AMBRA1\u2013BCL2-Family Proteins Relationship, 330 (2017) 85\u2013113.","DOI":"10.1016\/bs.ircmb.2016.09.002"},{"issue":"44","key":"10.1016\/j.prp.2023.155023_bib187","first-page":"43628","article-title":"Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons","volume":"278","author":"Goldberg","year":"2003"},{"key":"10.1016\/j.prp.2023.155023_bib188","doi-asserted-by":"crossref","unstructured":"H. Yang, H. Wang, Y. Shu, X. Li, miR-103 promotes neurite outgrowth and suppresses cells apoptosis by targeting prostaglandin-endoperoxide synthase 2 in cellular models of Alzheimer\u2019s disease 12 (2018) 91.","DOI":"10.3389\/fncel.2018.00091"},{"key":"10.1016\/j.prp.2023.155023_bib189","doi-asserted-by":"crossref","unstructured":"A. Jauhari, T. Singh, S. Mishra, J. Shankar, S. Yadav, Coordinated action of miR-146a and parkin gene regulate rotenone-induced, neurodegeneration 176 (2) (2020) 433\u2013445.","DOI":"10.1093\/toxsci\/kfaa066"},{"key":"10.1016\/j.prp.2023.155023_bib190","doi-asserted-by":"crossref","unstructured":"H.R. Ghaiad, M. A Abd-Elmawla, E.S. Gad, K. A Ahmed, M. Abdelmonem, Modulating miR-146a Expression by Hydrogen Sulfide Ameliorates Motor Dysfunction and Axonal Demyelination in Cuprizone-Induced Multiple, Sclerosis 14 (17) (2023) 3047\u20133058.","DOI":"10.1021\/acschemneuro.3c00141"},{"key":"10.1016\/j.prp.2023.155023_bib191","doi-asserted-by":"crossref","unstructured":"N.M. Aborehab, M.A. Abd-Elmawla, A.M. ElSayed, O. Sabry, S.M. Ezzat, Acovenoside A as a novel therapeutic approach to boost taxol and carboplatin apoptotic and antiproliferative activities in NSCLC: Interplay of miR-630\/miR-181a and apoptosis genes, 139 (2023) 106743.","DOI":"10.1016\/j.bioorg.2023.106743"},{"issue":"27","key":"10.1016\/j.prp.2023.155023_bib192","first-page":"42274","article-title":"MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis","volume":"7","author":"Cheng","year":"2016"},{"key":"10.1016\/j.prp.2023.155023_bib193","doi-asserted-by":"crossref","unstructured":"S.V. Hegarty, A.M. Sullivan, G.W. O\u2019Keeffe, Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1\/5-dependent mechanism: implications for Parkinson\u2019s, disease 2 (1) (2018) NS20170181.","DOI":"10.1042\/NS20170181"},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib194","first-page":"355","article-title":"miR-218 inhibits mitochondrial clearance by targeting PRKN E3 ubiquitin ligase","volume":"21","author":"Di Rita","year":"2020"},{"key":"10.1016\/j.prp.2023.155023_bib195","doi-asserted-by":"crossref","unstructured":"R.X. Xing, L.G. Li, X.W. Liu, B.X. Tian, Y. Cheng, Down regulation of miR\u2010218, miR\u2010124, and miR\u2010144 relates to Parkinson\u2019s disease via activating NF\u2010\u03baB, signaling 36 (10) (2020) 786\u2013792.","DOI":"10.1002\/kjm2.12241"},{"key":"10.1016\/j.prp.2023.155023_bib196","doi-asserted-by":"crossref","unstructured":"X. Ma, H. Zhang, H. Yin, S. Geng, Y. Liu, C. Liu, J. Zhao, Y. Liu, X. Wang, Y. Wang, Up-regulated microRNA-218\u20135p ameliorates the damage of dopaminergic neurons in rats with Parkinson\u2019s disease via suppression of LASP1, 166 (2021) 92\u2013101.","DOI":"10.1016\/j.brainresbull.2020.10.019"},{"key":"10.1016\/j.prp.2023.155023_bib197","doi-asserted-by":"crossref","unstructured":"X. Dong, X. He, L. Yang, Q. Li, Y. Xu, Inhibition of miR-421 preserves mitochondrial function and protects against Parkinson\u2019s disease pathogenesis via Pink1\/Parkin-dependent mitophagy, 2022 (2022).","DOI":"10.1155\/2022\/5186252"},{"key":"10.1016\/j.prp.2023.155023_bib198","doi-asserted-by":"crossref","unstructured":"Y. Zhou, Y. Liu, Z. Kang, H. Yao, N. Song, M. Wang, C. Song, K. Zhang, J. Ding, J. Tang, CircEPS15, as a sponge of MIR24\u20133p ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagy, (2023) 1\u201318.","DOI":"10.1080\/15548627.2023.2196889"},{"key":"10.1016\/j.prp.2023.155023_bib199","doi-asserted-by":"crossref","unstructured":"A. Gao, J. Jiang, F. Xie, L. Chen, Bnip3 in mitophagy: Novel insights and potential therapeutic target for diseases of secondary mitochondrial dysfunction 506 (2020) 72\u201383.","DOI":"10.1016\/j.cca.2020.02.024"},{"key":"10.1016\/j.prp.2023.155023_bib200","doi-asserted-by":"crossref","unstructured":"D.-X. Wang, Y. Yang, X.-S. Huang, J.-Y. Tang, X. Zhang, H.-X. Huang, B. Zhou, B. Liu, H.-Q. Xiao, X.-H. Li, Pramipexole attenuates neuronal injury in Parkinson's disease by targeting miR-96 to activate BNIP3-mediated mitophagy, 146 (2021) 104972.","DOI":"10.1016\/j.neuint.2021.104972"},{"key":"10.1016\/j.prp.2023.155023_bib201","doi-asserted-by":"crossref","unstructured":"C. L\u00fccking, A.J.C. Brice*, M.L. CMLS, Alpha-synuclein and Parkinson\u2019s disease 57 (2000) 1894\u20131908.","DOI":"10.1007\/PL00000671"},{"key":"10.1016\/j.prp.2023.155023_bib202","doi-asserted-by":"crossref","unstructured":"P. Magalh\u00e3es, H.A. Lashuel, Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson\u2019s disease and other synucleinopathies 8 (1) (2022) 93.","DOI":"10.1038\/s41531-022-00357-0"},{"key":"10.1016\/j.prp.2023.155023_bib203","doi-asserted-by":"crossref","unstructured":"K.J. McMillan, T.K. Murray, N. Bengoa-Vergniory, O. Cordero-Llana, J. Cooper, A. Buckley, R. Wade-Martins, J.B. Uney, M.J. O\u2019Neill, L.F. Wong, Loss of microRNA-7 regulation leads to \u03b1-synuclein accumulation and dopaminergic neuronal loss in, vivo 25 (10) (2017) 2404\u20132414.","DOI":"10.1016\/j.ymthe.2017.08.017"},{"key":"10.1016\/j.prp.2023.155023_bib204","doi-asserted-by":"crossref","unstructured":"J. Jiang, R. Xiong, J. Lu, X. Wang, X. Gu, MicroRNA-203a-3p regulates the apoptosis of MPP+ Induced SH-SY5Y cells by targeting, A-synuclein 10 (6) (2020) 838\u2013844.","DOI":"10.1166\/jbt.2020.2320"},{"key":"10.1016\/j.prp.2023.155023_bib205","doi-asserted-by":"crossref","unstructured":"Z.-H. Wang, J.-L. Zhang, Y.-L. Duan, Q.-S. Zhang, G.-F. Li, D.-L. Zheng, MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting \u03b1-synuclein expression in MPTP-induced Parkinson\u2019s disease mouse 74 (2015) 252\u2013256.","DOI":"10.1016\/j.biopha.2015.08.025"},{"key":"10.1016\/j.prp.2023.155023_bib206","doi-asserted-by":"crossref","unstructured":"P. Tarale, A.P. Daiwile, S. Sivanesan, R. St\u00f6ger, A. Bafana, P.K. Naoghare, D. Parmar, T. Chakrabarti, K. Krishnamurthi, Manganese exposure: Linking down-regulation of miRNA-7 and miRNA-433 with \u03b1-synuclein overexpression and risk of idiopathic, Parkinson\u2019s disease 46 (2018) 94\u2013101.","DOI":"10.1016\/j.tiv.2017.10.003"},{"key":"10.1016\/j.prp.2023.155023_bib207","doi-asserted-by":"crossref","unstructured":"Yf Shen, Zy Zhu, Sx Qian, Cy Xu, Yp. Wang, behavior, miR\u201030b protects nigrostriatal dopaminergic neurons from MPP (+)\u2010induced neurotoxicity via, SNCA 10 (4) (2020) e01567.","DOI":"10.1002\/brb3.1567"},{"key":"10.1016\/j.prp.2023.155023_bib208","doi-asserted-by":"crossref","unstructured":"G. Je, Y.-S. Kim, Mitochondrial ROS-mediated post-transcriptional regulation of \u03b1-synuclein through miR-7 and miR-153, 661 (2017) 132\u2013136.","DOI":"10.1016\/j.neulet.2017.09.065"},{"key":"10.1016\/j.prp.2023.155023_bib209","doi-asserted-by":"crossref","unstructured":"L. Wu, Q. Xu, M. Zhou, Y. Chen, C. Jiang, Y. Jiang, Y. Lin, Q. He, L. Zhao, Y. Dong, Plasma miR-153 and miR-223 levels as potential biomarkers in Parkinson\u2019s disease 16 (2022) 865139.","DOI":"10.3389\/fnins.2022.865139"},{"key":"10.1016\/j.prp.2023.155023_bib210","doi-asserted-by":"crossref","unstructured":"Shamsuzzama, L. Kumar, A. Nazir, Modulation of alpha-synuclein expression and associated effects by microRNA let-7 in transgenic C. elegans, 10 (2017) 328.","DOI":"10.3389\/fnmol.2017.00328"},{"key":"10.1016\/j.prp.2023.155023_bib211","doi-asserted-by":"crossref","unstructured":"S. Gehrke, Y. Imai, N. Sokol, B. Lu, Pathogenic LRRK2 negatively regulates microRNA-mediated translational, repression 466 (7306) (2010) 637\u2013641.","DOI":"10.1038\/nature09191"},{"key":"10.1016\/j.prp.2023.155023_bib212","doi-asserted-by":"crossref","unstructured":"H.J. Cho, G. Liu, S.M. Jin, L. Parisiadou, C. Xie, J. Yu, L. Sun, B. Ma, J. Ding, R.J.Hmg Vancraenenbroeck, MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein, 22(3) (2013) 608\u2013620.","DOI":"10.1093\/hmg\/dds470"},{"key":"10.1016\/j.prp.2023.155023_bib213","doi-asserted-by":"crossref","unstructured":"X. Lin, L. Parisiadou, X.-L. Gu, L. Wang, H. Shim, L. Sun, C. Xie, C.-X. Long, W.-J. Yang, J. Ding, Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant \u03b1-synuclein 64 (6) (2009) 807\u2013827.","DOI":"10.1016\/j.neuron.2009.11.006"},{"key":"10.1016\/j.prp.2023.155023_bib214","unstructured":"Q. Wu, D.-Z. Xi, Y.-H. Wang, MicroRNA-599 regulates the development of Parkinson\u2019s disease through mediating LRRK2 expression 23 (2) (2019)."},{"key":"10.1016\/j.prp.2023.155023_bib215","doi-asserted-by":"crossref","unstructured":"W. Jin, Novel insights into PARK7 (DJ-1), a potential anti-cancer therapeutic target, and implications for cancer progression 9 (5) (2020) 1256.","DOI":"10.3390\/jcm9051256"},{"key":"10.1016\/j.prp.2023.155023_bib216","doi-asserted-by":"crossref","unstructured":"F. Lind-Holm Mogensen, A. Scafidi, A. Poli, A. Michelucci, PARK7\/DJ-1 in microglia: implications in Parkinson\u2019s disease and relevance as a therapeutic, target 20 (1) (2023) 1\u201319.","DOI":"10.1186\/s12974-023-02776-z"},{"key":"10.1016\/j.prp.2023.155023_bib217","doi-asserted-by":"crossref","unstructured":"I. Irrcher, H. Aleyasin, E. Seifert, S. Hewitt, S. Chhabra, M. Phillips, A. Lutz, M. Rousseaux, L. Bevilacqua, A. Jahani-Asl, Loss of the Parkinson\u2019s disease-linked gene DJ-1 perturbs mitochondrial, dynamics 19 (19) (2010) 3734\u20133746.","DOI":"10.1093\/hmg\/ddq288"},{"key":"10.1016\/j.prp.2023.155023_bib218","doi-asserted-by":"crossref","unstructured":"R. Xiong, Z. Wang, Z. Zhao, H. Li, W. Chen, B. Zhang, L. Wang, L. Wu, W. Li, J. Ding, MicroRNA-494 reduces DJ-1 expression and exacerbates, neurodegeneration 35 (3) (2014) 705\u2013714.","DOI":"10.1016\/j.neurobiolaging.2013.09.027"},{"key":"10.1016\/j.prp.2023.155023_bib219","doi-asserted-by":"crossref","unstructured":"Y. Chen, C. Gao, Q. Sun, H. Pan, P. Huang, J. Ding, S. Chen, MicroRNA-4639 is a regulator of DJ-1 expression and a potential early diagnostic marker for, Parkinson\u2019s disease 9 (2017) 232.","DOI":"10.3389\/fnagi.2017.00232"},{"key":"10.1016\/j.prp.2023.155023_bib220","doi-asserted-by":"crossref","unstructured":"Y. Chen, J. Zheng, L. Su, F. Chen, R. Zhu, X. Chen, Q. Ye, Increased salivary microRNAs that regulate DJ-1 gene expression as potential markers for Parkinson\u2019s disease 12 (2020) 210.","DOI":"10.3389\/fnagi.2020.00210"},{"key":"10.1016\/j.prp.2023.155023_bib221","doi-asserted-by":"crossref","unstructured":"S.E. Oh, H.-J. Park, L. He, C. Skibiel, E. Junn, M.M. Mouradian, The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress, 19 (2018) 62\u201373.","DOI":"10.1016\/j.redox.2018.07.021"},{"key":"10.1016\/j.prp.2023.155023_bib222","doi-asserted-by":"crossref","unstructured":"S. Kabaria, D.C. Choi, A.D. Chaudhuri, M.M. Mouradian, E. Junn, Inhibition of miR-34b and miR-34c enhances \u03b1-synuclein expression in Parkinson\u2019s disease 589 (3) (2015) 319\u2013325.","DOI":"10.1016\/j.febslet.2014.12.014"},{"key":"10.1016\/j.prp.2023.155023_bib223","doi-asserted-by":"crossref","unstructured":"E. Minones-Moyano, S. Porta, G. Escaram\u00eds, R. Rabionet, S. Iraola, B. Kagerbauer, Y. Espinosa-Parrilla, I. Ferrer, X. Estivill, E. Mart\u00ed, MicroRNA profiling of Parkinson\u2019s disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial, function 20 (15) (2011) 3067\u20133078.","DOI":"10.1093\/hmg\/ddr210"},{"key":"10.1016\/j.prp.2023.155023_bib224","doi-asserted-by":"crossref","unstructured":"I. Villar-Men\u00e9ndez, S. Porta, S.P. Buira, T. Pereira-Veiga, S. D\u00edaz-S\u00e1nchez, J.L. Albasanz, I. Ferrer, M. Mart\u00edn, M. Barrachina, Increased striatal adenosine A2A receptor levels is an early event in Parkinson\u2019s disease-related pathology and it is potentially regulated by miR-34b, 69 (2014) 206\u2013214.","DOI":"10.1016\/j.nbd.2014.05.030"},{"key":"10.1016\/j.prp.2023.155023_bib225","doi-asserted-by":"crossref","unstructured":"M.A. Abd-Elmawla, Y.A. Elsabagh, N.M. Aborehab, Association of XIST\/miRNA155\/Gab2\/TAK1 cascade with the pathogenesis of anti-phospholipid syndrome and its effect on cell adhesion molecules and inflammatory, mediators 13 (1) (2023) 18790.","DOI":"10.1038\/s41598-023-45214-z"},{"issue":"8","key":"10.1016\/j.prp.2023.155023_bib226","first-page":"2383","article-title":"microRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease","volume":"36","author":"Thome","year":"2016"},{"key":"10.1016\/j.prp.2023.155023_bib227","doi-asserted-by":"crossref","unstructured":"J.-h Kim, I. Jou, E.-H. Joe, Suppression of miR-155 expression in IFN-\u03b3-treated astrocytes and microglia by DJ-1: a possible mechanism for maintaining SOCS1 expression 23 (2) (2014) 148.","DOI":"10.5607\/en.2014.23.2.148"},{"key":"10.1016\/j.prp.2023.155023_bib228","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00221-017-4989-1","article-title":"MicroRNAs in Parkinson\u2019s disease","volume":"235","author":"Singh","year":"2017","journal-title":"Exp. brain Res."},{"issue":"12","key":"10.1016\/j.prp.2023.155023_bib229","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1089\/dna.2020.5931","article-title":"Differential expression of microRNA Profiles and Wnt signals in stem cell-derived exosomes during dopaminergic neuron differentiation","volume":"39","author":"Jin","year":"2020","journal-title":"DNA Cell Biol."},{"issue":"23","key":"10.1016\/j.prp.2023.155023_bib230","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.3390\/ijms20236055","article-title":"Interplay between MicroRNAs and oxidative stress in neurodegenerative diseases","volume":"20","author":"Konovalova","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.prp.2023.155023_bib231","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.3390\/ijms21113995","article-title":"Molecular regulation in dopaminergic neuron development. Cues to unveil molecular pathogenesis and pharmacological targets of neurodegeneration","volume":"21","author":"Volpicelli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.155023_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136638","article-title":"Circular RNA circTLK1 regulates dopaminergic neuron injury during Parkinson\u2018s disease by targeting miR-26a-5p\/DAPK1","volume":"782","author":"Chen","year":"2022","journal-title":"Neurosci. Lett."},{"issue":"13","key":"10.1016\/j.prp.2023.155023_bib233","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.3390\/ijms20133131","article-title":"Death-associated protein kinase 1 phosphorylation in neuronal cell death and neurodegenerative disease","volume":"20","author":"Kim","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib234","article-title":"A regulatory loop containing miR-26a, GSK3\u03b2 and C\/EBP\u03b1 regulates the osteogenesis of human adipose-derived mesenchymal stem cells","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.prp.2023.155023_bib235","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2174\/1570159X17666190726115623","article-title":"Emerging perspectives on DNA double-strand breaks in neurodegenerative diseases","volume":"17","author":"Zhu","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.prp.2023.155023_bib236","article-title":"The cross-links of endoplasmic reticulum stress","volume":"13","author":"Ren","year":"2021","journal-title":"autophagy, Neurodegener. Parkinson\u2019s Dis., Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.prp.2023.155023_bib237","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.biopsych.2018.12.008","article-title":"MicroRNA-26a\/death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson\u2019s disease","volume":"85","author":"Su","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.prp.2023.155023_bib238","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-020-00636-z","article-title":"Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases","volume":"27","author":"Wu","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.prp.2023.155023_bib239","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-018-1506-3","article-title":"MiR-218 produces anti-tumor effects on cervical cancer cells in vitro","volume":"16","author":"Zhu","year":"2018","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2023.155023_bib240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1073858417721150","article-title":"MicroRNAs: roles in regulating neuroinflammation","volume":"24","author":"Gaudet","year":"2018","journal-title":"Neuroscientist"},{"key":"10.1016\/j.prp.2023.155023_bib241","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2018.07.033","article-title":"Neuroinflammation in neurodegenerative diseases: current multi-modal imaging studies and future opportunities for hybrid PET\/MRI","volume":"403","author":"Aiello","year":"2019","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib242","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nri.2016.123","article-title":"Cytokine networks in neuroinflammation","volume":"17","author":"Becher","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.prp.2023.155023_bib243","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005264","article-title":"Peripherally derived macrophages modulate microglial function to reduce inflammation after CNS injury","volume":"16","author":"Greenhalgh","year":"2018","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib244","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/ncrna5020035","article-title":"MicroRNAs in neuroinflammation: implications in disease pathogenesis, biomarker discovery and therapeutic applications","volume":"5","author":"Slota","year":"2019","journal-title":"Non-coding RNA"},{"key":"10.1016\/j.prp.2023.155023_bib245","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3389\/fphys.2018.00686","article-title":"MiRNA-155 regulates the Th17\/Treg ratio by targeting SOCS1 in severe acute pancreatitis","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.prp.2023.155023_bib246","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","article-title":"microRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease","volume":"36","author":"Thome","year":"2016","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.prp.2023.155023_bib247","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10571-017-0572-3","article-title":"Up-regulated pro-inflammatory microRNAs (miRNAs) in Alzheimer\u2019s disease (AD) and age-related macular degeneration (AMD)","volume":"38","author":"Pogue","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.prp.2023.155023_bib248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt150","article-title":"NF-\u03baB-regulated, proinflammatory miRNAs in Alzheimer's disease","volume":"4","author":"Lukiw","year":"2012","journal-title":"Alzheimer'S. Res. Ther."},{"issue":"3","key":"10.1016\/j.prp.2023.155023_bib249","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1523\/JNEUROSCI.0851-16.2016","article-title":"miR-142-3p is a key regulator of IL-1\u03b2-dependent synaptopathy in neuroinflammation","volume":"37","author":"Mandolesi","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2023.155023_bib250","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3389\/fimmu.2018.01377","article-title":"Anti-inflammatory microRNAs and their potential for inflammatory diseases treatment","volume":"9","author":"Tahamtan","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-13-27","article-title":"miR-21 attenuates lipopolysaccharide-induced lipid accumulation and inflammatory response: potential role in cerebrovascular disease","volume":"13","author":"Feng","year":"2014","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib252","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-018-1053-4","article-title":"MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson\u2019s disease","volume":"15","author":"Yao","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.prp.2023.155023_bib253","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1096\/fj.201900363R","article-title":"MicroRNA\u2010124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease","volume":"33","author":"Yao","year":"2019","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.prp.2023.155023_bib254","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/jnc.13364","article-title":"microRNA\u201026a modulates inflammatory response induced by toll\u2010like receptor 4 stimulation in microglia","volume":"135","author":"Kumar","year":"2015","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib255","first-page":"953","article-title":"Protective effect of proanthocyanidins on nephrotoxicity induced by antitumor dose of cisplatin in ehrlich solid tumor-bearing mice","volume":"40","author":"Salman","year":"2014","journal-title":"Arab. J. Lab. Med"},{"issue":"10","key":"10.1016\/j.prp.2023.155023_bib256","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025443","article-title":"Convergence of miRNA expression profiling, \u03b1-synuclein interacton and GWAS in Parkinson's disease","volume":"6","author":"Martins","year":"2011","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.prp.2023.155023_bib257","doi-asserted-by":"crossref","first-page":"23379","DOI":"10.1002\/jcp.28907","article-title":"MicroRNA\u2010190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP\u2010induced Parkinson's disease mouse model","volume":"234","author":"Sun","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib258","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2011.05.044","article-title":"Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells","volume":"499","author":"Li","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.prp.2023.155023_bib259","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/jcbfm.2014.207","article-title":"Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-\u03baB activation","volume":"35","author":"Wu","year":"2015","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.prp.2023.155023_bib260","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fneur.2014.00181","article-title":"Up-regulation of miRNA-146a in progressive, age-related inflammatory neurodegenerative disorders of the human CNS","volume":"5","author":"Alexandrov","year":"2014","journal-title":"Front. Neurol."},{"issue":"12","key":"10.1016\/j.prp.2023.155023_bib261","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.4049\/jimmunol.1202496","article-title":"MicroRNA let-7c regulates macrophage polarization","volume":"190","author":"Banerjee","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2023.155023_bib262","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mcn.2015.07.004","article-title":"MicroRNA-Let-7a regulates the function of microglia in inflammation","volume":"68","author":"Cho","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib263","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056709","article-title":"Let-7b is involved in the inflammation and immune responses associated with Helicobacter pylori infection by targeting Toll-like receptor 4","volume":"8","author":"Teng","year":"2013","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.prp.2023.155023_bib264","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/emboj.2011.94","article-title":"Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let\u20107 family","volume":"30","author":"Schulte","year":"2011","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.prp.2023.155023_bib265","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/cells8050403","article-title":"Current challenges of iPSC-based disease modeling and therapeutic implications","volume":"8","author":"Doss","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.prp.2023.155023_bib266","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-019-0701-6","article-title":"Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson\u2019s disease patients","volume":"11","author":"Fern\u00e1ndez-Santiago","year":"2019","journal-title":"Clin. epigenetics"},{"issue":"3","key":"10.1016\/j.prp.2023.155023_bib267","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/hmg\/dds470","article-title":"MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein","volume":"22","author":"Cho","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.prp.2023.155023_bib268","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neurobiolaging.2018.05.032","article-title":"MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients","volume":"69","author":"Tolosa","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib269","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.parkreldis.2014.10.018","article-title":"miRNA expression is highly sensitive to a drug therapy in Parkinson's disease","volume":"21","author":"Alieva","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.prp.2023.155023_bib270","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2015.05.021","article-title":"Midbrain dopamine neurons in Parkinson\u05f3 s disease exhibit a dysregulated miRNA and target-gene network","volume":"1618","author":"Briggs","year":"2015","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.prp.2023.155023_bib271","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003973","article-title":"An Lmx1b-miR135a2 regulatory circuit modulates Wnt1\/Wnt signaling and determines the size of the midbrain dopaminergic progenitor pool","volume":"9","author":"Anderegg","year":"2013","journal-title":"PLoS Genet."},{"issue":"1\u20132","key":"10.1016\/j.prp.2023.155023_bib272","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000452521","article-title":"Involvement of microRNA-135a-5p in the protective effects of hydrogen sulfide against Parkinson's disease","volume":"40","author":"Liu","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2023.155023_bib273","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s12031-014-0428-y","article-title":"MiRNA profile in the substantia nigra of Parkinson\u2019s disease and healthy subjects","volume":"54","author":"Cardo","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.prp.2023.155023_bib274","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2014.04.026","article-title":"MicroRNA-135a and-200b, potential Biomarkers for Alzheimer\u05f3 s disease, regulate \u03b2 secretase and amyloid precursor protein","volume":"1583","author":"Liu","year":"2014","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.prp.2023.155023_bib275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005710","article-title":"GDNF overexpression from the native locus reveals its role in the nigrostriatal dopaminergic system function","volume":"11","author":"Kumar","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.prp.2023.155023_bib276","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2013.00040","article-title":"RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis","volume":"6","author":"Heman-Ackah","year":"2013","journal-title":"Front. Mol. Neurosci."},{"issue":"28","key":"10.1016\/j.prp.2023.155023_bib277","doi-asserted-by":"crossref","first-page":"E2851","DOI":"10.1073\/pnas.1407777111","article-title":"Two miRNA clusters, miR-34b\/c and miR-449, are essential for normal brain development, motile ciliogenesis, and spermatogenesis","volume":"111","author":"Wu","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.prp.2023.155023_bib278","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1517\/13543776.2014.965679","article-title":"miRNAs as novel therapeutic targets and diagnostic biomarkers for Parkinson\u2019s disease: a patent evaluation of WO2014018650","volume":"24","author":"Hesse","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib279","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/1354750X.2015.1118544","article-title":"A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson\u2019s disease","volume":"21","author":"Dong","year":"2016","journal-title":"Biomarkers"},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093751","article-title":"Studying the system-level involvement of microRNAs in Parkinson's disease","volume":"9","author":"Chatterjee","year":"2014","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.prp.2023.155023_bib281","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.neurobiolaging.2009.10.016","article-title":"Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation","volume":"32","author":"Mutez","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib282","first-page":"356","article-title":"Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin\u2010proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC\u201070","volume":"1053","author":"Mandel","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.prp.2023.155023_bib283","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.bbadis.2013.09.009","article-title":"LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4","volume":"1832","author":"H\u00e4big","year":"2013","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Mol. Basis Dis."},{"issue":"11","key":"10.1016\/j.prp.2023.155023_bib284","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.tibs.2012.08.003","article-title":"Extracellular miRNAs: the mystery of their origin and function","volume":"37","author":"Turchinovich","year":"2012","journal-title":"Trends Biochem. Sci."},{"issue":"13","key":"10.1016\/j.prp.2023.155023_bib285","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.3390\/ijms23137167","article-title":"MicroRNA-based diagnosis and therapy","volume":"23","author":"Ho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10110","key":"10.1016\/j.prp.2023.155023_bib286","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/S0140-6736(17)32399-1","article-title":"Why do so many clinical trials of therapies for Alzheimer's disease fail?","volume":"390","author":"Anderson","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib287","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/15622975.2017.1375556","article-title":"Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: an update of the Consensus of the Task Force on biological markers in psychiatry of the world federation of societies of biological psychiatry","volume":"19","author":"Lewczuk","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.prp.2023.155023_bib288","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.3390\/ijms23094610","article-title":"Molecular biomarkers and their implications for the early diagnosis of selected neurodegenerative diseases","volume":"23","author":"Doroszkiewicz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.155023_bib289","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1007\/s12035-016-0253-0","article-title":"MicroRNAs in cerebrospinal fluid as potential biomarkers for Parkinson\u2019s disease and multiple system atrophy","volume":"54","author":"Marques","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2023.155023_bib290","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fnins.2018.00625","article-title":"Circulating miRNAs as diagnostic biomarkers for Parkinson\u2019s disease","volume":"12","author":"Roser","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.prp.2023.155023_bib291","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ensci.2018.09.002","article-title":"Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients","volume":"13","author":"Caggiu","year":"2018","journal-title":"Eneurologicalsci"},{"issue":"35","key":"10.1016\/j.prp.2023.155023_bib292","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","article-title":"Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease","volume":"6","author":"Gui","year":"2015","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.prp.2023.155023_bib293","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.3390\/ijms20225649","article-title":"Role of MicroRNAs in Parkinson\u2019s disease","volume":"20","author":"Goh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5842","key":"10.1016\/j.prp.2023.155023_bib294","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1140481","article-title":"A MicroRNA feedback circuit in midbrain dopamine neurons","volume":"317","author":"Kim","year":"2007","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.prp.2023.155023_bib295","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","article-title":"MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function","volume":"20","author":"Minones-Moyano","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.prp.2023.155023_bib296","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ymthe.2017.08.017","article-title":"Loss of microRNA-7 regulation leads to \u03b1-synuclein accumulation and dopaminergic neuronal loss in vivo","volume":"25","author":"McMillan","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.prp.2023.155023_bib297","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fncel.2015.00193","article-title":"An updated role of microRNA-124 in central nervous system disorders: a review","volume":"9","author":"Sun","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.prp.2023.155023_bib298","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2021.104588","article-title":"Neuroprotective effects of microRNA 124 in Parkinson's disease mice","volume":"99","author":"Zhang","year":"2022","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.prp.2023.155023_bib299","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fneur.2012.00012","article-title":"LRRK2 in transcription and translation regulation: relevance for Parkinson\u2019s disease","volume":"3","author":"Dorval","year":"2012","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib300","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.bbrc.2019.08.140","article-title":"miR-let-7a suppresses \u03b1-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease","volume":"519","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.prp.2023.155023_bib301","article-title":"MicroRNA\u2010150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease, Molecular Genetics & Genomic","volume":"8","author":"Li","year":"2020","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib302","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000518212","article-title":"LncRNA RMST regulates neuronal apoptosis and inflammatory response via sponging miR-150-5p in Parkinson\u2019s disease","volume":"29","author":"Chen","year":"2022","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib303","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2567.2011.03514.x","article-title":"miR\u2010155 modulates microglia\u2010mediated immune response by down\u2010regulating SOCS\u20101 and promoting cytokine and nitric oxide production","volume":"135","author":"Cardoso","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.prp.2023.155023_bib304","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fncel.2017.00170","article-title":"Reduced circulating levels of miR-433 and miR-133b are potential biomarkers for Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.prp.2023.155023_bib305","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.536913","article-title":"MiR-433 inhibits neuronal growth and promotes autophagy in mouse hippocampal HT-22 cell line","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2023.155023_bib306","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.744942","article-title":"MicroRNAs Play a Role in Parkinson\u2019s Disease by Regulating Microglia Function: From Pathogenetic Involvement to Therapeutic Potential","volume":"14","author":"Li","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"8","key":"10.1016\/j.prp.2023.155023_bib307","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.23153","article-title":"Downregulation of miR\u20107116\u20135p in microglia by MPP+ sensitizes TNF\u2010\u03b1 production to induce dopaminergic neuron damage","volume":"65","author":"He","year":"2017","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.prp.2023.155023_bib308","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41419-019-1809-5","article-title":"miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson\u2019s disease","volume":"10","author":"Hu","year":"2019","journal-title":"Cell death Dis."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib309","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.prp.2023.155023_bib310","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neuroscience.2018.07.019","article-title":"Long noncoding RNA SNHG1 promotes neuroinflammation in Parkinson\u2019s disease via regulating miR-7\/NLRP3 pathway","volume":"388","author":"Cao","year":"2018","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib311","first-page":"993","article-title":"MicroRNA-7 inhibits neuronal apoptosis in a cellular Parkinson\u2019s disease model by targeting Bax and Sirt2","volume":"8","author":"Li","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.prp.2023.155023_bib312","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1566523218666180430121323","article-title":"miR-7 replacement therapy in Parkinson's disease","volume":"18","author":"Titze-de-Almeida","year":"2018","journal-title":"Curr. gene Ther."},{"issue":"3","key":"10.1016\/j.prp.2023.155023_bib313","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/1440-1681.13212","article-title":"MiR\u201029c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1","volume":"47","author":"Wang","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"6","key":"10.1016\/j.prp.2023.155023_bib314","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/gtc.12764","article-title":"miR\u201029c\u20103p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson's disease","volume":"25","author":"Wang","year":"2020","journal-title":"Genes Cells"},{"issue":"9","key":"10.1016\/j.prp.2023.155023_bib315","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/gtc.12877","article-title":"miR\u201029c\u20103p regulates TET2 expression and inhibits autophagy process in Parkinson's disease models","volume":"26","author":"Wang","year":"2021","journal-title":"Genes Cells"},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib316","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","article-title":"MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson\u2019s disease by targeting Nlrp3","volume":"31","author":"Li","year":"2018","journal-title":"Hum. Cell"},{"key":"10.1016\/j.prp.2023.155023_bib317","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00415-020-10291-x","article-title":"Nanoparticles for drug delivery in Parkinson\u2019s disease","volume":"268","author":"Baskin","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.prp.2023.155023_bib318","article-title":"Design, optimization, and in-vivo performance of glipizide-loaded O-carboxymethyl chitosan nanoparticles in insulin resistant\/type 2 diabetic rat model","volume":"79","author":"El-Dakroury","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.prp.2023.155023_bib319","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154704","article-title":"miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma","author":"Elkady","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib320","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154684","article-title":"miRNAs orchestration of gallbladder cancer-Particular emphasis on diagnosis, progression and drug resistance","author":"Shahin","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib321","doi-asserted-by":"crossref","DOI":"10.1016\/j.apmt.2022.101560","article-title":"Smart\/stimuli-responsive hydrogels: state-of-the-art platforms for bone tissue engineering","author":"El-Husseiny","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.prp.2023.155023_bib322","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1174075","article-title":"Stimuli-responsive hydrogels: smart state of-the-art platforms for cardiac tissue engineering","volume":"11","author":"El-Husseiny","year":"2023","journal-title":"Front Bioeng. Biotechnol."},{"key":"10.1016\/j.prp.2023.155023_bib323","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154715","article-title":"Decoding the role of miRNAs in multiple myeloma pathogenesis: a focus on signaling pathways","author":"Yehia","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib324","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154690","article-title":"The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma-a focus on signaling pathways interplay","author":"Midan","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.155023_bib325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122006","article-title":"Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation","volume":"624","author":"Zewail","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.prp.2023.155023_bib326","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123224","article-title":"Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis","volume":"643","author":"Zewail","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.prp.2023.155023_bib327","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03733-8","article-title":"Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2023.155023_bib328","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120786","article-title":"Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease","volume":"272","author":"Olson","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.prp.2023.155023_bib329","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jconrel.2016.06.005","article-title":"MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.prp.2023.155023_bib330","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7150\/thno.16562","article-title":"Inhibition by multifunctional magnetic nanoparticles loaded with alpha-synuclein RNAi plasmid in a Parkinson's disease model","volume":"7","author":"Niu","year":"2017","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.prp.2023.155023_bib331","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1021\/acs.molpharmaceut.7b01084","article-title":"In vivo introduction of mRNA encapsulated in lipid nanoparticles to brain neuronal cells and astrocytes via intracerebroventricular administration","volume":"15","author":"Tanaka","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.prp.2023.155023_bib332","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.omtn.2017.08.013","article-title":"Polyethylenimine nanoparticle-mediated siRNA delivery to reduce \u03b1-Synuclein expression in a model of Parkinson\u2019s disease","volume":"9","author":"Helmschrodt","year":"2017","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.prp.2023.155023_bib333","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118449","article-title":"Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson\u2019s disease model","volume":"567","author":"Gan","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.prp.2023.155023_bib334","article-title":"Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson\u2019s disease","volume":"8","author":"Liu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2023.155023_bib335","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jconrel.2022.06.024","article-title":"Development of an extended half-life GM-CSF fusion protein for Parkinson's disease","volume":"348","author":"Yeapuri","year":"2022","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.prp.2023.155023_bib336","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1021\/acsnano.7b08172","article-title":"Targeted brain delivery of rabies virus glycoprotein 29-modified deferoxamine-loaded nanoparticles reverses functional deficits in parkinsonian mice","volume":"12","author":"You","year":"2018","journal-title":"Acs Nano"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823007240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823007240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:54:36Z","timestamp":1730894076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823007240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":336,"alternative-id":["S0344033823007240"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.155023","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.155023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155023"}}